Since 1959, The Medical Letter on Drugs & Therapeutics is the most trusted source of unbiased drug information. This reference contains critical appraisals of new drugs and comparative reviews of older drugs. The editorial process relies on a consensus of experts to develop prescribing recommendations that are completely independent of the pharmaceutical industry.
Key Features
- Bi-weekly subscription for the latest drug information
- FREE of advertising, and without pharmaceutical or government influence
- Concise, timely, and unbiased prescribing recommendations for drugs used by almost every medical specialty
- Represents the combined viewpoints of specialists in their respective fields, with special emphasis placed on published clinical trials
- Access to archived articles up to 5 years back
The Medical Letter on Drugs & Therapeutics is a fee-based subscription for MedStream, Skyscape's dynamic information channel service. With MedStream, you'll stay up-to-date on a broad range of medical news and journal articles. Your paid subscription for The Medical Letter on Drugs & Therapeutics also includes access to the following renowned and trusted content: MedWatch, CDC Spotlights, Preventing Chronic Disease and MEDLINE.
Facts About Skyscape's PDA Medical Software
The Medical Letter on Drugs and Therapeutics is current, accurate and easily cross-indexes with all of Skyscape's 500+ clinical, drug & diagnostic references.
Privacy Policy
Twitter
and
Facebook